Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

Source: CNBC | Published: March 29, 2025, 7:02 p.m.

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

Read Original Article Back to News List

Related News

TikTok creators, partners remain optimistic ahead of app’s second ban deadline

3 hours, 43 minutes ago

Federal funding cuts are raising questions about university endowments. Here's what some are worth and how they work

3 hours, 43 minutes ago

Euro zone inflation dips to 2.2% in March as U.S. tariffs loom

4 hours, 22 minutes ago

French politics to get 'even messier' as far-right figurehead Le Pen rails against ban, analysts warn

7 hours, 29 minutes ago

China kicks off military drills near Taiwan, warns island's 'independence' means war

9 hours, 32 minutes ago